Sudha, a lot 20 year old female developed antibiotic associated pseudomembranous colotis caused by Costridium difficile. Whinch of the following drugs is most likely to be effective in the treatment of this disease?
**Core Concept**
Antibiotic-associated pseudomembranous colitis, caused by Clostridium difficile (C. difficile), is a gastrointestinal infection characterized by the formation of pseudomembranes in the colon. This condition often occurs as a result of the disruption of the normal gut microbiota due to broad-spectrum antibiotic use.
**Why the Correct Answer is Right**
Vancomycin is a glycopeptide antibiotic that is effective against C. difficile due to its ability to inhibit cell wall synthesis in the bacteria. Vancomycin is not absorbed from the gastrointestinal tract, allowing it to act locally on the infected colon. This mechanism makes it an ideal choice for treating C. difficile infections, particularly in cases where oral administration is necessary.
**Why Each Wrong Option is Incorrect**
**Option A:** Metronidazole is an antibiotic that is effective against anaerobic bacteria, but it may not be as effective as vancomycin in treating C. difficile infections, especially in severe cases. Its efficacy is also limited by the development of resistance.
**Option B:** Ciprofloxacin is a fluoroquinolone antibiotic that is effective against a wide range of bacteria, but it is not typically used to treat C. difficile infections due to the risk of worsening the infection.
**Option C:** Amoxicillin-clavulanate is a beta-lactam antibiotic combination that is effective against a variety of bacterial infections, but it is not effective against C. difficile and may even contribute to the development of the infection.
**Clinical Pearl / High-Yield Fact**
In cases of C. difficile infection, it is essential to discontinue the offending antibiotic and initiate treatment with a specific antibiotic, such as vancomycin, to prevent further complications and promote recovery.
**Correct Answer:** A. Vancomycin. Vancomycin is the most likely effective drug in the treatment of C. difficile infection due to its ability to inhibit cell wall synthesis in the bacteria and its localized action in the colon.